気道感染症治療の世界市場（～2026年）

• 英文タイトル：Global Respiratory Tract Infection Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04493
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は気道感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗生物質、NSAIDS、咳止め薬、鼻充血除去薬、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別気道感染症治療の競争状況、市場シェア
・世界の気道感染症治療市場：種類別市場規模 2015年-2020年（抗生物質、NSAIDS、咳止め薬、鼻充血除去薬、その他）
・世界の気道感染症治療市場：種類別市場規模予測 2021年-2026年（抗生物質、NSAIDS、咳止め薬、鼻充血除去薬、その他）
・世界の気道感染症治療市場：用途別市場規模 2015年-2020年（病院、クリニック）
・世界の気道感染症治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック）
・北米の気道感染症治療市場分析：米国、カナダ
・ヨーロッパの気道感染症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの気道感染症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の気道感染症治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの気道感染症治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Abbott、AstraZeneca、Abbvie、Boehringer Ingelheim、Cipla Pharmaceutical、GlaxoSmithkline、Pfizer、Merck、Novartis、Roche、Sanofi、Teva
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Respiratory Tract Infection Treatment Market
The global Respiratory Tract Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Respiratory Tract Infection Treatment Scope and Market Size
Respiratory Tract Infection Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Tract Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott
AstraZeneca
Abbvie
Boehringer Ingelheim
Cipla Pharmaceutical
GlaxoSmithkline
Pfizer
Merck
Novartis
Roche
Sanofi
Teva

Market segment by Type, the product can be split into
Antibiotics
NSAIDS
Cough Suppressant
Nose Decongestant
Others
Market segment by Application, split into
Hospital
Clinic

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Respiratory Tract Infection Treatment Revenue
1.4 Market by Type
1.4.1 Global Respiratory Tract Infection Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 NSAIDS
1.4.4 Cough Suppressant
1.4.5 Nose Decongestant
1.4.6 Others
1.5 Market by Application
1.5.1 Global Respiratory Tract Infection Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Tract Infection Treatment Market Perspective (2015-2026)
2.2 Global Respiratory Tract Infection Treatment Growth Trends by Regions
2.2.1 Respiratory Tract Infection Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Respiratory Tract Infection Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Respiratory Tract Infection Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Respiratory Tract Infection Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Respiratory Tract Infection Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Tract Infection Treatment Players by Market Size
3.1.1 Global Top Respiratory Tract Infection Treatment Players by Revenue (2015-2020)
3.1.2 Global Respiratory Tract Infection Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Respiratory Tract Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Respiratory Tract Infection Treatment Market Concentration Ratio
3.2.1 Global Respiratory Tract Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Respiratory Tract Infection Treatment Revenue in 2019
3.3 Respiratory Tract Infection Treatment Key Players Head office and Area Served
3.4 Key Players Respiratory Tract Infection Treatment Product Solution and Service
3.5 Date of Enter into Respiratory Tract Infection Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Respiratory Tract Infection Treatment Historic Market Size by Type (2015-2020)
4.2 Global Respiratory Tract Infection Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Respiratory Tract Infection Treatment Market Size by Application (2015-2020)
5.2 Global Respiratory Tract Infection Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Respiratory Tract Infection Treatment Market Size (2015-2020)
6.2 Respiratory Tract Infection Treatment Key Players in North America (2019-2020)
6.3 North America Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
6.4 North America Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Respiratory Tract Infection Treatment Market Size (2015-2020)
7.2 Respiratory Tract Infection Treatment Key Players in Europe (2019-2020)
7.3 Europe Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
7.4 Europe Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

8 China
8.1 China Respiratory Tract Infection Treatment Market Size (2015-2020)
8.2 Respiratory Tract Infection Treatment Key Players in China (2019-2020)
8.3 China Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
8.4 China Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Respiratory Tract Infection Treatment Market Size (2015-2020)
9.2 Respiratory Tract Infection Treatment Key Players in Japan (2019-2020)
9.3 Japan Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
9.4 Japan Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Respiratory Tract Infection Treatment Market Size (2015-2020)
10.2 Respiratory Tract Infection Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

11 India
11.1 India Respiratory Tract Infection Treatment Market Size (2015-2020)
11.2 Respiratory Tract Infection Treatment Key Players in India (2019-2020)
11.3 India Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
11.4 India Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Respiratory Tract Infection Treatment Market Size (2015-2020)
12.2 Respiratory Tract Infection Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
12.4 Central & South America Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Respiratory Tract Infection Treatment Introduction
13.1.4 Abbott Revenue in Respiratory Tract Infection Treatment Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Respiratory Tract Infection Treatment Introduction
13.2.4 AstraZeneca Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Abbvie
13.3.1 Abbvie Company Details
13.3.2 Abbvie Business Overview
13.3.3 Abbvie Respiratory Tract Infection Treatment Introduction
13.3.4 Abbvie Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.3.5 Abbvie Recent Development
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Details
13.4.2 Boehringer Ingelheim Business Overview
13.4.3 Boehringer Ingelheim Respiratory Tract Infection Treatment Introduction
13.4.4 Boehringer Ingelheim Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.4.5 Boehringer Ingelheim Recent Development
13.5 Cipla Pharmaceutical
13.5.1 Cipla Pharmaceutical Company Details
13.5.2 Cipla Pharmaceutical Business Overview
13.5.3 Cipla Pharmaceutical Respiratory Tract Infection Treatment Introduction
13.5.4 Cipla Pharmaceutical Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.5.5 Cipla Pharmaceutical Recent Development
13.6 GlaxoSmithkline
13.6.1 GlaxoSmithkline Company Details
13.6.2 GlaxoSmithkline Business Overview
13.6.3 GlaxoSmithkline Respiratory Tract Infection Treatment Introduction
13.6.4 GlaxoSmithkline Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.6.5 GlaxoSmithkline Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Respiratory Tract Infection Treatment Introduction
13.7.4 Pfizer Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck Respiratory Tract Infection Treatment Introduction
13.8.4 Merck Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview
13.9.3 Novartis Respiratory Tract Infection Treatment Introduction
13.9.4 Novartis Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Roche
13.10.1 Roche Company Details
13.10.2 Roche Business Overview
13.10.3 Roche Respiratory Tract Infection Treatment Introduction
13.10.4 Roche Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
13.10.5 Roche Recent Development
13.11 Sanofi
10.11.1 Sanofi Company Details
10.11.2 Sanofi Business Overview
10.11.3 Sanofi Respiratory Tract Infection Treatment Introduction
10.11.4 Sanofi Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
10.11.5 Sanofi Recent Development
13.12 Teva
10.12.1 Teva Company Details
10.12.2 Teva Business Overview
10.12.3 Teva Respiratory Tract Infection Treatment Introduction
10.12.4 Teva Revenue in Respiratory Tract Infection Treatment Business (2015-2020)
10.12.5 Teva Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Respiratory Tract Infection Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Respiratory Tract Infection Treatment Revenue
Table 3. Ranking of Global Top Respiratory Tract Infection Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Respiratory Tract Infection Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of NSAIDS
Table 7. Key Players of Cough Suppressant
Table 8. Key Players of Nose Decongestant
Table 9. Key Players of Others
Table 10. Global Respiratory Tract Infection Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Respiratory Tract Infection Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Respiratory Tract Infection Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Respiratory Tract Infection Treatment Market Share by Regions (2015-2020)
Table 14. Global Respiratory Tract Infection Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Respiratory Tract Infection Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Respiratory Tract Infection Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Respiratory Tract Infection Treatment Players
Table 21. Global Respiratory Tract Infection Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Respiratory Tract Infection Treatment Market Share by Players (2015-2020)
Table 23. Global Top Respiratory Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Tract Infection Treatment as of 2019)
Table 24. Global Respiratory Tract Infection Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Respiratory Tract Infection Treatment Product Solution and Service
Table 27. Date of Enter into Respiratory Tract Infection Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Respiratory Tract Infection Treatment Market Size Share by Type (2015-2020)
Table 31. Global Respiratory Tract Infection Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Respiratory Tract Infection Treatment Market Size Share by Application (2015-2020)
Table 33. Global Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Respiratory Tract Infection Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 37. North America Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 39. North America Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 43. Europe Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 45. Europe Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 49. China Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 51. China Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 55. Japan Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 57. Japan Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 61. Southeast Asia Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 67. India Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 69. India Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 73. Central & South America Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Product
Table 80. Abbott Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 81. Abbott Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Product
Table 85. AstraZeneca Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 86. AstraZeneca Recent Development
Table 87. Abbvie Company Details
Table 88. Abbvie Business Overview
Table 89. Abbvie Product
Table 90. Abbvie Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 91. Abbvie Recent Development
Table 92. Boehringer Ingelheim Company Details
Table 93. Boehringer Ingelheim Business Overview
Table 94. Boehringer Ingelheim Product
Table 95. Boehringer Ingelheim Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 96. Boehringer Ingelheim Recent Development
Table 97. Cipla Pharmaceutical Company Details
Table 98. Cipla Pharmaceutical Business Overview
Table 99. Cipla Pharmaceutical Product
Table 100. Cipla Pharmaceutical Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 101. Cipla Pharmaceutical Recent Development
Table 102. GlaxoSmithkline Company Details
Table 103. GlaxoSmithkline Business Overview
Table 104. GlaxoSmithkline Product
Table 105. GlaxoSmithkline Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 106. GlaxoSmithkline Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Product
Table 110. Pfizer Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 111. Pfizer Recent Development
Table 112. Merck Business Overview
Table 113. Merck Product
Table 114. Merck Company Details
Table 115. Merck Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 116. Merck Recent Development
Table 117. Novartis Company Details
Table 118. Novartis Business Overview
Table 119. Novartis Product
Table 120. Novartis Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 121. Novartis Recent Development
Table 122. Roche Company Details
Table 123. Roche Business Overview
Table 124. Roche Product
Table 125. Roche Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 126. Roche Recent Development
Table 127. Sanofi Company Details
Table 128. Sanofi Business Overview
Table 129. Sanofi Product
Table 130. Sanofi Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 131. Sanofi Recent Development
Table 132. Teva Company Details
Table 133. Teva Business Overview
Table 134. Teva Product
Table 135. Teva Revenue in Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 136. Teva Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Tract Infection Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. NSAIDS Features
Figure 4. Cough Suppressant Features
Figure 5. Nose Decongestant Features
Figure 6. Others Features
Figure 7. Global Respiratory Tract Infection Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Respiratory Tract Infection Treatment Report Years Considered
Figure 11. Global Respiratory Tract Infection Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Respiratory Tract Infection Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Respiratory Tract Infection Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Respiratory Tract Infection Treatment Market Share by Players in 2019
Figure 16. Global Top Respiratory Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Tract Infection Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Respiratory Tract Infection Treatment Revenue in 2019
Figure 18. North America Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

下気道感染症治療の世界市場（～2026年）

Global Lower Respiratory Tract Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12541 2020年11月25日 96Pages
当調査資料は下気道感染症治療のグローバル市場について調査・分析したレポートです。種類別（サポーティブケア、ホスピタルケア、ドラッグ、ワクチン）市場規模、用途別（病院、クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

尿路感染症治療の世界市場（～2026年）

Global Urinary Tract Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04952 2020年11月20日 99Pages
当調査資料は尿路感染症治療のグローバル市場について調査・分析したレポートです。種類別（複雑なUTI、再発性の複雑なUTI、単純なUTI、神経因性膀胱感染症、その他）市場規模、用途別（病院薬局、婦人科および泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア）市場規模、地域別（北米、...

医療関連感染（HAI）治療の世界市場（～2026年）

Global Hospital Acquired Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12229 2020年11月25日 133Pages
当調査資料は医療関連感染（HAI）治療のグローバル市場について調査・分析したレポートです。種類別（尿路感染症、換気装置関連肺炎、手術部位感染症、血流感染症、胃腸感染症、耳鼻咽喉科感染症、皮膚感染症、骨感染症）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米...

耳感染症治療の世界市場（～2026年）

Global Ear Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11736 2020年11月25日 99Pages
当調査資料は耳感染症治療のグローバル市場について調査・分析したレポートです。種類別（手術、薬剤、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、...

帯状疱疹感染症治療の世界市場（～2026年）

Global Herpes Zoster Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12180 2020年11月25日 94Pages
当調査資料は帯状疱疹感染症治療のグローバル市場について調査・分析したレポートです。種類別（経口、局所、非経口）市場規模、用途別（クリニック、病院、診断センター、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

全身感染症治療の世界市場（～2026年）

Global Systemic Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04785 2020年11月20日 92Pages
当調査資料は全身感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗ウイルス、防カビ）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台...

クロストリジウム・ディフィシル感染症治療の世界市場（～2026年）

Global Clostridium Difficile Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11404 2020年11月25日 93Pages
当調査資料はクロストリジウム・ディフィシル感染症治療のグローバル市場について調査・分析したレポートです。種類別（経口型、注射可能型）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、オンライン販売）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、ア...

歯科用感染症治療の世界市場（～2026年）

Global Dental Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11607 2020年11月25日 94Pages
当調査資料は歯科用感染症治療のグローバル市場について調査・分析したレポートです。種類別（根尖性膿瘍、歯周膿瘍、その他）市場規模、用途別（歯科医院、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

牛呼吸器疾患治療の世界市場（～2026年）

Global Bovine Respiratory Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11176 2020年11月25日 98Pages
当調査資料は牛呼吸器疾患治療のグローバル市場について調査・分析したレポートです。種類別（ワクチン、抗生物質、免疫調節剤、その他）市場規模、用途別（獣医クリニック、獣医病院、獣医研究所、民間獣医薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

水痘帯状疱疹感染症治療薬の世界市場（～2026年）

Global Varicella Zoster Infection Treatment Drugs Market Insights and Forecast to 2026
MRC2-11QY12960 2020年11月30日 115Pages
当調査資料は水痘帯状疱疹感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（アシクロビル、バラシクロビル、ファムシクロビル、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…
尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
医療関連感染（HAI）治療の世界市場（～2026年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million b…
耳感染症治療の世界市場（～2026年） An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the th…
帯状疱疹感染症治療の世界市場（～2026年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…